Transcatheter Aortic Valve Replacement (TAVR) Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Procedure (Transfemoral, Transapical, Transaortic, Subclavian, Others), and Region    

Transcatheter Aortic Valve Replacement (TAVR) Devices Market size was valued at US$ 11.9 billion in 2023, growing at a CAGR of 21.1% from  2024-2030. TAVR devices Market is a new technology that has recently been shown to improve survival and quality of life in patients with severe symptomatic aortic stenosis who are not surgical candidates. The development and design of transcatheter valves has been ongoing for the past 20 years and TAVR has been approved recently by GDA for treatment of aortic stenosis in patients who are not surgical candidates. Transcatheter Aortic Valve Replacement (TAVR) Devices Market players are focusing on R&D investments to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in the market. For instance, transcatheter aortic valve replacement or transcatheter aortic valve implantation has become a novel procedure for patients who are considered at high risk for standard valve replacement therapy. Apart from this, companies also focus on mergers and acquisitions to enhance their market share.  

Transcatheter Aortic Valve Replacement (TAVR) Devices Market Key Developments:

• In 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.